Small Molecule API Market – Regional insights
North America held the largest market share for small molecule API registering for 38.84% in 2017, due to high adoption rate of accelerated regulatory review of innovative medicines. Asia Pacific excluding Japan (APEJ) market is estimated to witness rapid growth in market, owing to high adoption of over the counter (OTC) drugs by large patient population coupled with growing healthcare and pharmaceutical industry and strong research and development in API. According to IBEF, investment in research and development by Indian pharmaceutical companies increased (in term of sales) from 5.3% to 8.5% from 2012 to 2018.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients